{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:52:00Z","timestamp":1785941520242,"version":"3.56.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"DOI":"10.7759\/cureus.76842","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T10:03:32Z","timestamp":1735898612000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rapid Review of Adenocarcinoma and Pulmonary Tumor Thrombotic Microangiopathy: A Deadly Duo"],"prefix":"10.7759","author":[{"given":"Emin","family":"Gayibov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin H","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1358","article-title":"Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition)","volume":"132","author":"Spiro SG","year":"2007","unstructured":"Spiro SG, Gould MK, Colice GL. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007, 132:149S-60S. 10.1378\/chest.07-1358","journal-title":"Chest"},{"key":"ref2","article-title":"Paraneoplastic syndromes","author":"Thapa B","year":"2024","unstructured":"Thapa B, Mahendraker N, Ramphul K. Paraneoplastic syndromes. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-005-0942-1","article-title":"Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature","volume":"263","author":"Baijens LW","year":"2006","unstructured":"Baijens LW, Manni JJ. Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature. Eur Arch Otorhinolaryngol. 2006, 263:32-6. 10.1007\/s00405-005-0942-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-03053-3","article-title":"Paraneoplastic neurological syndromes: a single institution 10-year case series","volume":"141","author":"Chan AM","year":"2019","unstructured":"Chan AM, Baehring JM. Paraneoplastic neurological syndromes: a single institution 10-year case series. J Neurooncol. 2019, 141:431-9. 10.1007\/s11060-018-03053-3","journal-title":"J Neurooncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1756285611405395","article-title":"Current approaches to the treatment of paraneoplastic encephalitis","volume":"4","author":"Grisold W","year":"2011","unstructured":"Grisold W, Giometto B, Vitaliani R, Oberndorfer S. Current approaches to the treatment of paraneoplastic encephalitis. Ther Adv Neurol Disord. 2011, 4:237-48. 10.1177\/1756285611405395","journal-title":"Ther Adv Neurol Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-012-0213-6","article-title":"Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia","volume":"15","author":"van Sonderen A","year":"2013","unstructured":"van Sonderen A, Wirtz PW, Verschuuren JJ, Titulaer MJ. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia. Curr Treat Options Neurol. 2013, 15:224-39. 10.1007\/s11940-012-0213-6","journal-title":"Curr Treat Options Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.618","article-title":"Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature","volume":"15","author":"Barbosa SL","year":"2005","unstructured":"Barbosa SL, Rodien P, Leboulleux S, et al.. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid. 2005, 15:618-23. 10.1089\/thy.2005.15.618","journal-title":"Thyroid"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0936-3","article-title":"SIADH: differential diagnosis and clinical management","volume":"55","author":"Peri A","year":"2017","unstructured":"Peri A, Groh\u00e9 C, Berardi R, Runkle I. SIADH: differential diagnosis and clinical management. Endocrine. 2017, 55:311-9. 10.1007\/s12020-016-0936-3","journal-title":"Endocrine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3382","article-title":"Management of non-islet-cell tumor hypoglycemia: a clinical review","volume":"99","author":"Bodnar TW","year":"2014","unstructured":"Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review. J Clin Endocrinol Metab. 2014, 99:713-22. 10.1210\/jc.2013-3382","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7186","article-title":"Carcinoid syndrome: a review","volume":"12","author":"Gade AK","year":"2020","unstructured":"Gade AK, Olariu E, Douthit NT. Carcinoid syndrome: a review. Cureus. 2020, 12:e7186. 10.7759\/cureus.7186","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105173442017","article-title":"Paraneoplastic hyperaldosteronism associated with non-Hodgkin's lymphoma","volume":"344","author":"Mulatero P","year":"2001","unstructured":"Mulatero P, Rabbia F, Veglio F. Paraneoplastic hyperaldosteronism associated with non-Hodgkin's lymphoma. N Engl J Med. 2001, 344:1558-9. 10.1056\/NEJM200105173442017","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2020.04.002","article-title":"Paraneoplastic musculoskeletal syndromes","volume":"46","author":"Khan F","year":"2020","unstructured":"Khan F, Kleppel H, Meara A. Paraneoplastic musculoskeletal syndromes. Rheum Dis Clin North Am. 2020, 46:577-86. 10.1016\/j.rdc.2020.04.002","journal-title":"Rheum Dis Clin North Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328359e780","article-title":"Paraneoplastic rheumatologic syndromes","volume":"25","author":"Azar L","year":"2013","unstructured":"Azar L, Khasnis A. Paraneoplastic rheumatologic syndromes. Curr Opin Rheumatol. 2013, 25:44-9. 10.1097\/BOR.0b013e328359e780","journal-title":"Curr Opin Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2018.1031","article-title":"The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome","volume":"70","author":"Muller S","year":"2018","unstructured":"Muller S, Hider S, Helliwell T, Partington R, Mallen C. The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome. Reumatismo. 2018, 70:23-34. 10.4081\/reumatismo.2018.1031","journal-title":"Reumatismo"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V75.3.577.577","article-title":"Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia","volume":"75","author":"Da Silva JL","year":"1990","unstructured":"Da Silva JL, Lacombe C, Bruneval P, et al.. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood. 1990, 75:577-82.","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02682.x","article-title":"Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis","volume":"113","author":"Suzuki M","year":"2001","unstructured":"Suzuki M, Takamizawa S, Nomaguchi K, Suzu S, Yamada M, Igarashi T, Sato I. Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis. Br J Haematol. 2001, 113:49-51. 10.1046\/j.1365-2141.2001.02682.x","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861201)58:11<2485::aid-cncr2820581122>3.0.co;2-n","article-title":"Serum erythropoietin concentrations in patients with hepatocellular carcinoma","volume":"58","author":"Kew MC","year":"1986","unstructured":"Kew MC, Fisher JW. Serum erythropoietin concentrations in patients with hepatocellular carcinoma. Cancer. 1986, 58:2485-8. 10.1002\/1097-0142(19861201)58:11&lt;2485::aid-cncr2820581122&gt;3.0.co;2-n","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4372","article-title":"Paraneoplastic dermatological manifestation of gastrointestinal malignancies","volume":"15","author":"Dourmishev LA","year":"2009","unstructured":"Dourmishev LA, Draganov PV. Paraneoplastic dermatological manifestation of gastrointestinal malignancies. World J Gastroenterol. 2009, 15:4372-9. 10.3748\/wjg.15.4372","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2019.01.001","article-title":"Cutaneous paraneoplastic syndromes","volume":"36","author":"Wick MR","year":"2019","unstructured":"Wick MR, Patterson JW. Cutaneous paraneoplastic syndromes. Semin Diagn Pathol. 2019, 36:211-28. 10.1053\/j.semdp.2019.01.001","journal-title":"Semin Diagn Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.229260","article-title":"Paraneoplastic glomerulopathies associated with hematologic malignancies","volume":"29","author":"Dhanapriya J","year":"2018","unstructured":"Dhanapriya J, Dineshkumar T, Sakthirajan R, Surendar D, Gopalakrishnan N, Balasubramaniyan T. Paraneoplastic glomerulopathies associated with hematologic malignancies. Saudi J Kidney Dis Transpl. 2018, 29:452-5. 10.4103\/1319-2442.229260","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.05.002","article-title":"Risk and prognosis of cancer in patients with nephrotic syndrome","volume":"127","author":"Christiansen CF","year":"2014","unstructured":"Christiansen CF, Onega T, Sv\u00e6rke C, K\u00f6rmendin\u00e9 Farkas D, Jespersen B, Baron JA, S\u00f8rensen HT. Risk and prognosis of cancer in patients with nephrotic syndrome. Am J Med. 2014, 127:871-7.e1. 10.1016\/j.amjmed.2014.05.002","journal-title":"Am J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000339126","article-title":"Pulmonary lymphangitic carcinomatosis due to renal cell carcinoma","volume":"5","author":"Guddati AK","year":"2012","unstructured":"Guddati AK, Marak CP. Pulmonary lymphangitic carcinomatosis due to renal cell carcinoma. Case Rep Oncol. 2012, 5:246-52. 10.1159\/000339126","journal-title":"Case Rep Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0260IM","article-title":"Paraneoplastic pulmonary alveolar proteinosis","volume":"205","author":"Leick M","year":"2022","unstructured":"Leick M, Chen YB. Paraneoplastic pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2022, 205:e55. 10.1164\/rccm.202202-0260IM","journal-title":"Am J Respir Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.9472","article-title":"Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases","volume":"52","author":"Uruga H","year":"2013","unstructured":"Uruga H, Fujii T, Kurosaki A, et al.. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med. 2013, 52:1317-23. 10.2169\/internalmedicine.52.9472","journal-title":"Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019851000","article-title":"Pulmonary tumor thrombotic microangiopathy: a systematic review","volume":"9","author":"Godbole RH","year":"2019","unstructured":"Godbole RH, Saggar R, Kamangar N. Pulmonary tumor thrombotic microangiopathy: a systematic review. Pulm Circ. 2019, 9:2045894019851000. 10.1177\/2045894019851000","journal-title":"Pulm Circ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900801)66:3<587::aid-cncr2820660330>3.0.co;2-j","article-title":"Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension","volume":"66","author":"von Herbay A","year":"1990","unstructured":"von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990, 66:587-92. 10.1002\/1097-0142(19900801)66:3&lt;587::aid-cncr2820660330&gt;3.0.co;2-j","journal-title":"Cancer"},{"key":"ref27","unstructured":"Connected Papers | Find and explore academic papers [Internet]. (2024). Accessed. March 25, 2024: http:\/\/www.connectedpapers.com."},{"key":"ref28","unstructured":"Mendeley - Reference Management Software &amp; Researcher Network [Internet]. (2024). Accessed. March 25, 2024: http:\/\/www.mendeley.com."},{"key":"ref29","article-title":"Pulmonary tumor embolism: a critical review of clinical, imaging, and hemodynamic features","volume":"2","author":"Chan CK","year":"1987","unstructured":"Chan CK, Hutcheon MA, Hyland RH, Smith GJ, Patterson BJ, Matthay RA. Pulmonary tumor embolism: a critical review of clinical, imaging, and hemodynamic features. J Thorac Imaging. 1987, 2:4-14.","journal-title":"J Thorac Imaging"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(03)00305-x","article-title":"Pulmonary tumor embolism: a review of the literature","volume":"115","author":"Roberts KE","year":"2003","unstructured":"Roberts KE, Hamele-Bena D, Saqi A, Stein CA, Cole RP. Pulmonary tumor embolism: a review of the literature. Am J Med. 2003, 115:228-32. 10.1016\/s0002-9343(03)00305-x","journal-title":"Am J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2018.07.007","article-title":"Beyond pulmonary embolism; nonthrombotic pulmonary embolism as diagnostic challenges","volume":"48","author":"McCabe BE","year":"2019","unstructured":"McCabe BE, Veselis CA, Goykhman I, Hochhold J, Eisenberg D, Son H. Beyond pulmonary embolism; nonthrombotic pulmonary embolism as diagnostic challenges. Curr Probl Diagn Radiol. 2019, 48:387-92. 10.1067\/j.cpradiol.2018.07.007","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s1092-9134(00)90038-8","article-title":"Tumor-related thrombotic pulmonary microangiopathy: review of pathologic findings and pathophysiologic mechanisms","volume":"4","author":"Pinckard JK","year":"2000","unstructured":"Pinckard JK, Wick MR. Tumor-related thrombotic pulmonary microangiopathy: review of pathologic findings and pathophysiologic mechanisms. Ann Diagn Pathol. 2000, 4:154-7. 10.1016\/s1092-9134(00)90038-8","journal-title":"Ann Diagn Pathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/23971983241296721","article-title":"Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension","author":"Friedman SH","year":"2024","unstructured":"Friedman SH, Harley RA, Williams J, et al.. Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. J Scleroderma Relat Disord. 2024, 23971983241296721. 10.1177\/23971983241296721","journal-title":"J Scleroderma Relat Disord"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/37.3.2918221","article-title":"Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes","volume":"37","author":"Skalli O","year":"1989","unstructured":"Skalli O, Pelte MF, Peclet MC, et al.. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem. 1989, 37:315-21. 10.1177\/37.3.2918221","journal-title":"J Histochem Cytochem"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00052-2015","article-title":"Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?","volume":"46","author":"Kumar N","year":"2015","unstructured":"Kumar N, Price LC, Montero MA, Dimopoulos K, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?. Eur Respir J. 2015, 46:1214-7. 10.1183\/13993003.00052-2015","journal-title":"Eur Respir J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1737.98853","article-title":"Pulmonary tumor thrombotic microangiopathy caused by gastric cancer","volume":"7","author":"Kuwabara H","year":"2012","unstructured":"Kuwabara H, Yoshida S, Takasu T, Yuki M, Goto I, Hanafusa T, Shibayama Y. Pulmonary tumor thrombotic microangiopathy caused by gastric cancer. Ann Thorac Med. 2012, 7:168-9. 10.4103\/1817-1737.98853","journal-title":"Ann Thorac Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1995.tb03481.x","article-title":"Pulmonary tumor thrombotic microangiopathy","volume":"45","author":"Sato Y","year":"1995","unstructured":"Sato Y, Marutsuka K, Asada Y, Yamada M, Setoguchi T, Sumiyoshi A. Pulmonary tumor thrombotic microangiopathy. Pathol Int. 1995, 45:436-40. 10.1111\/j.1440-1827.1995.tb03481.x","journal-title":"Pathol Int"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-6-27","article-title":"Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases","volume":"6","author":"Okubo Y","year":"2011","unstructured":"Okubo Y, Wakayama M, Kitahara K, et al.. Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol. 2011, 6:27. 10.1186\/1746-1596-6-27","journal-title":"Diagn Pathol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.5758","article-title":"Pulmonary tumor thrombotic microangiopathy caused by urothelial carcinoma expressing vascular endothelial growth factor, platelet-derived growth factor, and osteopontin","volume":"55","author":"Wakabayashi Y","year":"2016","unstructured":"Wakabayashi Y, Iwaya M, Akita M, Takeuchi W, Yamazaki K, Iijima A. Pulmonary tumor thrombotic microangiopathy caused by urothelial carcinoma expressing vascular endothelial growth factor, platelet-derived growth factor, and osteopontin. Intern Med. 2016, 55:651-6. 10.2169\/internalmedicine.55.5758","journal-title":"Intern Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65690","article-title":"Pulmonary tumor thrombotic microangiopathy with versican expression in a patient with advanced gastric cancer: a case report of a rare autopsy","volume":"16","author":"Muramatsu S","year":"2024","unstructured":"Muramatsu S, Fujiwara M, Kazunari K, Watanabe M, Watanabe N. Pulmonary tumor thrombotic microangiopathy with versican expression in a patient with advanced gastric cancer: a case report of a rare autopsy. Cureus. 2024, 16:e65690. 10.7759\/cureus.65690","journal-title":"Cureus"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1086\/686994","article-title":"Versican accumulates in vascular lesions in pulmonary arterial hypertension","volume":"6","author":"Chang YT","year":"2016","unstructured":"Chang YT, Chan CK, Eriksson I, et al.. Versican accumulates in vascular lesions in pulmonary arterial hypertension. Pulm Circ. 2016, 6:347-59. 10.1086\/686994","journal-title":"Pulm Circ"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng Z","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J. TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024, 9:61. 10.1038\/s41392-024-01764-w","journal-title":"Signal Transduct Target Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2014.01.011","article-title":"A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease","volume":"34","author":"Chang MY","year":"2014","unstructured":"Chang MY, Tanino Y, Vidova V, et al.. A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biol. 2014, 34:1-12. 10.1016\/j.matbio.2014.01.011","journal-title":"Matrix Biol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117202","article-title":"Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors","volume":"93","author":"Kirchhofer D","year":"1994","unstructured":"Kirchhofer D, Tschopp TB, Hadv\u00e1ry P, Baumgartner HR. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest. 1994, 93:2073-83. 10.1172\/JCI117202","journal-title":"J Clin Invest"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i43.4757","article-title":"Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation","volume":"17","author":"Lee NK","year":"2011","unstructured":"Lee NK, Kim S, Kim HS, et al.. Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation. World J Gastroenterol. 2011, 17:4757-71. 10.3748\/wjg.v17.i43.4757","journal-title":"World J Gastroenterol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-368514","article-title":"Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome","volume":"118","author":"Shao B","year":"2011","unstructured":"Shao B, Wahrenbrock MG, Yao L, et al.. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood. 2011, 118:4015-23. 10.1182\/blood-2011-07-368514","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"Geddings JE","year":"2013","unstructured":"Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood. 2013, 122:1873-80. 10.1182\/blood-2013-04-460139","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12197","article-title":"The role of ADAMTS-13 and von Willebrand factor in cancer patients: results from the Vienna Cancer and Thrombosis Study","volume":"3","author":"Obermeier HL","year":"2019","unstructured":"Obermeier HL, Riedl J, Ay C, et al.. The role of ADAMTS-13 and von Willebrand factor in cancer patients: results from the Vienna Cancer and Thrombosis Study. Res Pract Thromb Haemost. 2019, 3:503-14. 10.1002\/rth2.12197","journal-title":"Res Pract Thromb Haemost"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13205","article-title":"ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer","volume":"14","author":"P\u00e9pin M","year":"2016","unstructured":"P\u00e9pin M, Kleinjan A, Hajage D, et al.. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer. J Thromb Haemost. 2016, 14:306-15. 10.1111\/jth.13205","journal-title":"J Thromb Haemost"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari M","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010, 28:e72-91. 10.1111\/j.1755-5922.2010.00171.x","journal-title":"Cardiovasc Ther"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1641-23","article-title":"Pulmonary tumor thrombotic microangiopathy caused by metastatic ovarian cancer: an antemortem diagnosis with pulmonary aspiration cytopathology","volume":"62","author":"Unno K","year":"2023","unstructured":"Unno K, Ohtani H, Sakamoto A, et al.. Pulmonary tumor thrombotic microangiopathy caused by metastatic ovarian cancer: an antemortem diagnosis with pulmonary aspiration cytopathology. Intern Med. 2023, 62:3649-55. 10.2169\/internalmedicine.1641-23","journal-title":"Intern Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-2220","article-title":"Bevacizumab combined with pemetrexed successfully treated lung adenocarcinoma complicated with pulmonary tumor thrombotic microangiopathy: a case report and literature review","volume":"10","author":"Lu L","year":"2021","unstructured":"Lu L, Wang Z, Li H, Li X, Ma S, Wang L, Yang B. Bevacizumab combined with pemetrexed successfully treated lung adenocarcinoma complicated with pulmonary tumor thrombotic microangiopathy: a case report and literature review. Ann Palliat Med. 2021, 10:767-77. 10.21037\/apm-20-2220","journal-title":"Ann Palliat Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1524-8","article-title":"Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report","volume":"11","author":"Miyazaki S","year":"2017","unstructured":"Miyazaki S, Ikeda T, Ito G, Inoue M, Nara K, Nishinaga Y, Hasegawa Y. Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report. J Med Case Rep. 2017, 11:356. 10.1186\/s13256-017-1524-8","journal-title":"J Med Case Rep"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0681-x","article-title":"Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab","volume":"18","author":"Suffredini DA","year":"2018","unstructured":"Suffredini DA, Lee JM, Peer CJ, Pratt D, Kleiner DE, Elinoff JM, Solomon MA. Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab. BMC Pulm Med. 2018, 18:112. 10.1186\/s12890-018-0681-x","journal-title":"BMC Pulm Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpccr.2023.100238","article-title":"A rare, life-threatening debut of pancreatic adenocarcinoma: pulmonary tumor thrombotic microangiopathy","volume":"10","author":"Jim\u00e9nez-Labaig P","year":"2023","unstructured":"Jim\u00e9nez-Labaig P, Fern\u00e1ndez Sol\u00e9 S, G\u00f3mez Varela S, Garc\u00eda Calvo J, Carrera Revilla S, Mu\u00f1oz Llarena A. A rare, life-threatening debut of pancreatic adenocarcinoma: pulmonary tumor thrombotic microangiopathy. Curr Probl Cancer Case Rep. 2023, 10:100238. 10.1016\/j.cpccr.2023.100238","journal-title":"Curr Probl Cancer Case Rep"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2022.0252","article-title":"Clinical course of suspected diagnosis of pulmonary tumor thrombotic microangiopathy: a 10-year experience of rapid progressive right ventricular failure syndrome in advanced cancer patients","volume":"53","author":"Bak M","year":"2023","unstructured":"Bak M, Kim M, Lee B, et al.. Clinical course of suspected diagnosis of pulmonary tumor thrombotic microangiopathy: a 10-year experience of rapid progressive right ventricular failure syndrome in advanced cancer patients. Korean Circ J. 2023, 53:170-84. 10.4070\/kcj.2022.0252","journal-title":"Korean Circ J"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2023.0019","article-title":"Pulmonary tumor thrombotic microangiopathy: an under-recognized potentially fatal cause of pulmonary hypertension","volume":"53","author":"Kim KA","year":"2023","unstructured":"Kim KA, Jung MH. Pulmonary tumor thrombotic microangiopathy: an under-recognized potentially fatal cause of pulmonary hypertension. Korean Circ J. 2023, 53:185-8. 10.4070\/kcj.2023.0019","journal-title":"Korean Circ J"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.19-549","article-title":"How to diagnose and treat pulmonary tumor thrombotic microangiopathy","volume":"61","author":"Onoda H","year":"2020","unstructured":"Onoda H, Imamura T, Inao K, Kinugawa K. How to diagnose and treat pulmonary tumor thrombotic microangiopathy. Int Heart J. 2020, 61:409-12. 10.1536\/ihj.19-549","journal-title":"Int Heart J"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3181966f5c","article-title":"Pulmonary tumor thrombotic microangiopathy: FDG-PET\/CT findings","volume":"34","author":"Tashima Y","year":"2009","unstructured":"Tashima Y, Abe K, Matsuo Y, et al.. Pulmonary tumor thrombotic microangiopathy: FDG-PET\/CT findings. Clin Nucl Med. 2009, 34:175-7. 10.1097\/RLU.0b013e3181966f5c","journal-title":"Clin Nucl Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2020.01.001","article-title":"Three cases of pulmonary tumor thrombotic microangiopathy (PTTM): challenge in antemortem diagnosis using lung perfusion blood volume images by dual-energy computed tomography","volume":"7","author":"Kamada H","year":"2020","unstructured":"Kamada H, Ota H, Terui Y, Sugimura K, Fukui S, Shimokawa H, Takase K. Three cases of pulmonary tumor thrombotic microangiopathy (PTTM): challenge in antemortem diagnosis using lung perfusion blood volume images by dual-energy computed tomography. Eur J Radiol Open. 2020, 7:100212. 10.1016\/j.ejro.2020.01.001","journal-title":"Eur J Radiol Open"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226678","article-title":"Clinical presentations and multimodal imaging diagnosis in chronic thromboembolic pulmonary hypertension","volume":"11","author":"Jung MH","year":"2022","unstructured":"Jung MH, Jung HO, Kwon SJ, Chang S. Clinical presentations and multimodal imaging diagnosis in chronic thromboembolic pulmonary hypertension. J Clin Med. 2022, 11:6678. 10.3390\/jcm11226678","journal-title":"J Clin Med"},{"key":"ref62","article-title":"Discussion","author":"Tran K","year":"2015","unstructured":"Tran K, Coyle K, Jabr MF, et al.. Discussion. Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness [Internet]. Tran K, Coyle K, Jabr MF, et al. (ed): Canadian Agency for Drugs and Technologies in Health, Ottawa; 2015."},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12278","article-title":"Pulmonary tumor thrombotic microangiopathy: exploration into current diagnostic aids and therapeutics","volume":"13","author":"Ramakrishnan P","year":"2023","unstructured":"Ramakrishnan P, Dahiya G, Lindstrom M, Thenappan T. Pulmonary tumor thrombotic microangiopathy: exploration into current diagnostic aids and therapeutics. Pulm Circ. 2023, 13:e12278. 10.1002\/pul2.12278","journal-title":"Pulm Circ"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/his.13813","article-title":"The pathological challenge of establishing a precise diagnosis for pulmonary tumour thrombotic microangiopathy: identification of new diagnostic criteria","volume":"74","author":"Sato N","year":"2019","unstructured":"Sato N, Tasaki T, Noguchi H, Irie K, Nakayama T. The pathological challenge of establishing a precise diagnosis for pulmonary tumour thrombotic microangiopathy: identification of new diagnostic criteria. Histopathology. 2019, 74:892-901. 10.1111\/his.13813","journal-title":"Histopathology"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.6705\/j.jacme.201809_8(3).0006","article-title":"Pulmonary tumor thrombotic microangiopathy: case report and literature review","volume":"8","author":"Chen CK","year":"2018","unstructured":"Chen CK. Pulmonary tumor thrombotic microangiopathy: case report and literature review. J Acute Med. 2018, 8:127-31. 10.6705\/j.jacme.201809_8(3).0006","journal-title":"J Acute Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2015.04.006","article-title":"A case of pulmonary tumour thrombotic microangiopathy","volume":"16","author":"McAnearney S","year":"2015","unstructured":"McAnearney S, Drain M. A case of pulmonary tumour thrombotic microangiopathy. Respir Med Case Rep. 2015, 16:7-10. 10.1016\/j.rmcr.2015.04.006","journal-title":"Respir Med Case Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000219","article-title":"Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature","volume":"93","author":"Gainza E","year":"2014","unstructured":"Gainza E, Fern\u00e1ndez S, Mart\u00ednez D, et al.. Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature. Medicine (Baltimore). 2014, 93:359-63. 10.1097\/MD.0000000000000219","journal-title":"Medicine (Baltimore)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.2379","article-title":"Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy","volume":"53","author":"Higo K","year":"2014","unstructured":"Higo K, Kubota K, Takeda A, Higashi M, Ohishi M. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med. 2014, 53:2595-9. 10.2169\/internalmedicine.53.2379","journal-title":"Intern Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpccr.2022.100173","article-title":"Early diagnosis and bevacizumab combined with chemotherapy improved pulmonary tumor thrombotic microangiopathy with lung adenocarcinoma: a case report","volume":"7","author":"Kotake T","year":"2022","unstructured":"Kotake T, Adachi Y, Honde K, et al.. Early diagnosis and bevacizumab combined with chemotherapy improved pulmonary tumor thrombotic microangiopathy with lung adenocarcinoma: a case report. Curr Probl Cancer Case Rep. 2022, 7:100173. 10.1016\/j.cpccr.2022.100173","journal-title":"Curr Probl Cancer Case Rep"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2021.101447","article-title":"Long-term survival of a patient with uterine cancer-induced pulmonary tumor thrombotic microangiopathy following treatment with platinum-based chemotherapy and bevacizumab: a case report","volume":"33","author":"Taniguchi J","year":"2021","unstructured":"Taniguchi J, Nakashima K, Matsuura T, et al.. Long-term survival of a patient with uterine cancer-induced pulmonary tumor thrombotic microangiopathy following treatment with platinum-based chemotherapy and bevacizumab: a case report. Respir Med Case Rep. 2021, 33:101447. 10.1016\/j.rmcr.2021.101447","journal-title":"Respir Med Case Rep"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080455","article-title":"Understanding and managing the possible adverse effects associated with bevacizumab","volume":"66","author":"Shord SS","year":"2009","unstructured":"Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm. 2009, 66:999-1013. 10.2146\/ajhp080455","journal-title":"Am J Health Syst Pharm"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.940906","article-title":"Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: a case report","volume":"24","author":"Padilha WS","year":"2023","unstructured":"Padilha WS, Cesar BN, Pacheco ST, De Sousa AA, Ledesma FL, Malheiros DM, Teixeira MC. Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: a case report. Am J Case Rep. 2023, 24:e940906. 10.12659\/AJCR.940906","journal-title":"Am J Case Rep"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.0718","article-title":"Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib","volume":"52","author":"Ogawa A","year":"2013","unstructured":"Ogawa A, Yamadori I, Matsubara O, Matsubara H. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med. 2013, 52:1927-30. 10.2169\/internalmedicine.52.0718","journal-title":"Intern Med"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1691","article-title":"Dramatic improvement of pulmonary tumor thrombotic microangiopathy in a breast cancer patient treated with bevacizumab","volume":"14","author":"Kimura A","year":"2023","unstructured":"Kimura A, Yamada A, Oshi M, et al.. Dramatic improvement of pulmonary tumor thrombotic microangiopathy in a breast cancer patient treated with bevacizumab. World J Oncol. 2023, 14:575-9. 10.14740\/wjon1691","journal-title":"World J Oncol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.19-556","article-title":"Imatinib dramatically improved pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy (PTTM) associated with metastatic breast cancer","volume":"61","author":"Yoshikawa S","year":"2020","unstructured":"Yoshikawa S, Hara T, Suzuki M, Fujioka M, Taniguchi Y, Hirata KI. Imatinib dramatically improved pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy (PTTM) associated with metastatic breast cancer. Int Heart J. 2020, 61:624-8. 10.1536\/ihj.19-556","journal-title":"Int Heart J"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-221032","article-title":"Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer","volume":"2017","author":"Kubota K","year":"2017","unstructured":"Kubota K, Shinozaki T, Imai Y, Kario K. Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer. BMJ Case Rep. 2017, 2017:bcr2017221032. 10.1136\/bcr-2017-221032","journal-title":"BMJ Case Rep"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.4274\/Tjh-2011.0018","article-title":"The side effects of imatinib","volume":"30","author":"Uzer E","year":"2013","unstructured":"Uzer E, Unal A, K\u00f6ker MY, Do\u011fan SA. The side effects of imatinib. Turk J Haematol. 2013, 30:341. 10.4274\/Tjh-2011.0018","journal-title":"Turk J Haematol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214568580","article-title":"Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate","volume":"22","author":"Ojeda-Uribe M","year":"2016","unstructured":"Ojeda-Uribe M, Merieau S, Guillon M, et al.. Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate. J Oncol Pharm Pract. 2016, 22:361-70. 10.1177\/1078155214568580","journal-title":"J Oncol Pharm Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/322071-a-rapid-review-of-adenocarcinoma-and-pulmonary-tumor-thrombotic-microangiopathy-a-deadly-duo","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T10:03:37Z","timestamp":1735898617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/322071-a-rapid-review-of-adenocarcinoma-and-pulmonary-tumor-thrombotic-microangiopathy-a-deadly-duo"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":78,"URL":"https:\/\/doi.org\/10.7759\/cureus.76842","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}